Personalized medicine has been touted as the next revolution in health care, but progress in bringing the right treatment to the right patient at the right time has been limited and will require some policy changes to blossom, according to Dr. Mark B. McClellan, former head of the U.S. Food and Drug Administration.
Research, Policy Advances Needed to Fulfill Promise of Genetic Medicine, Experts Say at AAAS 
